nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—Acetophenazine—DRD2—nicotine dependence	0.102	0.112	CrCbGaD
Cyamemazine—Triflupromazine—DRD2—nicotine dependence	0.0626	0.0686	CrCbGaD
Cyamemazine—Acepromazine—DRD2—nicotine dependence	0.0579	0.0634	CrCbGaD
Cyamemazine—Thioproperazine—DRD2—nicotine dependence	0.0566	0.062	CrCbGaD
Cyamemazine—Pipotiazine—DRD2—nicotine dependence	0.0557	0.061	CrCbGaD
Cyamemazine—Mesoridazine—DRD2—nicotine dependence	0.055	0.0602	CrCbGaD
Cyamemazine—Prochlorperazine—DRD2—nicotine dependence	0.0532	0.0583	CrCbGaD
Cyamemazine—Fluphenazine—DRD2—nicotine dependence	0.0481	0.0527	CrCbGaD
Cyamemazine—Propiomazine—DRD2—nicotine dependence	0.0463	0.0507	CrCbGaD
Cyamemazine—Chlorprothixene—DRD2—nicotine dependence	0.0438	0.048	CrCbGaD
Cyamemazine—Thioridazine—DRD2—nicotine dependence	0.0415	0.0454	CrCbGaD
Cyamemazine—Trimipramine—DRD2—nicotine dependence	0.0405	0.0444	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD2—nicotine dependence	0.0396	0.0434	CrCbGaD
Cyamemazine—Promethazine—DRD2—nicotine dependence	0.039	0.0427	CrCbGaD
Cyamemazine—Trifluoperazine—DRD2—nicotine dependence	0.0385	0.0421	CrCbGaD
Cyamemazine—Perphenazine—DRD2—nicotine dependence	0.0381	0.0417	CrCbGaD
Cyamemazine—Promazine—DRD2—nicotine dependence	0.0343	0.0376	CrCbGaD
Cyamemazine—Chlorpromazine—DRD2—nicotine dependence	0.0302	0.0331	CrCbGaD
Cyamemazine—Imipramine—DRD2—nicotine dependence	0.03	0.0329	CrCbGaD
Cyamemazine—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.0047	0.0541	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00408	0.047	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00401	0.0461	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00395	0.0455	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00343	0.0395	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00337	0.0388	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00309	0.0356	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00273	0.0315	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00239	0.0275	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00234	0.027	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00194	0.0224	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00192	0.0221	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00184	0.0212	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00169	0.0194	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00165	0.0191	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00159	0.0183	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00156	0.018	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00145	0.0167	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00142	0.0164	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00125	0.0144	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00115	0.0133	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0011	0.0126	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00109	0.0125	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00107	0.0124	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00107	0.0123	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000996	0.0115	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000952	0.011	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000935	0.0108	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000933	0.0107	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000916	0.0105	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000907	0.0104	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000865	0.00996	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000861	0.00991	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000849	0.00978	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000833	0.00959	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000818	0.00942	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000787	0.00907	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000782	0.009	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000777	0.00895	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000773	0.0089	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000747	0.00861	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000734	0.00845	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000711	0.00818	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000698	0.00803	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000679	0.00782	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000675	0.00777	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000666	0.00767	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000662	0.00763	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000592	0.00681	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000588	0.00678	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000514	0.00592	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000511	0.00588	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000504	0.00581	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000502	0.00578	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000462	0.00532	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000462	0.00532	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.00042	0.00484	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000408	0.0047	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000402	0.00462	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000401	0.00462	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000394	0.00454	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000394	0.00453	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000365	0.0042	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000358	0.00412	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000354	0.00408	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000348	0.004	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000334	0.00385	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000304	0.0035	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.00029	0.00334	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.000287	0.00331	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000285	0.00328	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000275	0.00317	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.000264	0.00304	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000259	0.00298	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.00025	0.00287	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.000248	0.00286	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000245	0.00282	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000239	0.00275	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000235	0.0027	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.000215	0.00248	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000211	0.00244	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	0.000179	0.00207	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	0.000156	0.00179	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000153	0.00176	CbGpPWpGaD
